Francesco Facchinetti

Francesco Facchinetti

UNVERIFIED PROFILE

Are you Francesco Facchinetti?   Register this Author

Register author
Francesco Facchinetti

Francesco Facchinetti

Publications by authors named "Francesco Facchinetti"

Are you Francesco Facchinetti?   Register this Author

40Publications

960Reads

18Profile Views

Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors.

Clin Cancer Res 2020 Feb 4;26(4):764-774. Epub 2019 Oct 4.

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-2035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024606PMC
February 2020

Digging into lorlatinib resistance in ALK-positive lung cancer: an editorial.

Chin Clin Oncol 2019 Oct 10;8(S1):S2. Epub 2018 Oct 10.

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://cco.amegroups.com/article/view/21761
Publisher Site
http://dx.doi.org/10.21037/cco.2018.09.04DOI Listing
October 2019

Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date.

Lung Cancer (Auckl) 2019 9;10:87-94. Epub 2019 Sep 9.

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/LCTT.S190786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747675PMC
September 2019

Advances in the prediction of long-term effectiveness of immune checkpoint blockers for non-small-cell lung cancer.

Immunotherapy 2019 08 19;11(12):993-1003. Epub 2019 Jul 19.

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2019-0107DOI Listing
August 2019

Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.

Handb Exp Pharmacol 2018;249:63-89

Medical Oncology Unit, University Hospital of Parma, Via Gramsci, 14, Parma, 43126, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/164_2017_16DOI Listing
June 2019

Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.

Cell Oncol (Dordr) 2019 Jun 9;42(3):261-273. Epub 2019 Apr 9.

Medical Oncology Unit, University Hospital of Parma, 43126, Parma, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13402-019-00441-3
Publisher Site
http://dx.doi.org/10.1007/s13402-019-00441-3DOI Listing
June 2019

Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib.

Invest New Drugs 2019 04 1;37(2):360-363. Epub 2018 Aug 1.

Medical Oncology Unit, University Hospital of Parma, Via Gramsci, 14, 43126, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0652-3DOI Listing
April 2019

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives.

Drug Des Devel Ther 2018 10;12:2857-2873. Epub 2018 Sep 10.

Medical Oncology Unit, University Hospital of Parma, Parma, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S124380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137949PMC
February 2019

Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?

Immunotherapy 2019 02;11(3):161-166

Medical Oncology Unit, Department of General and Specialistic Medicine, University Hospital of Parma, 43126 Parma, Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2018-0136
Publisher Site
http://dx.doi.org/10.2217/imt-2018-0136DOI Listing
February 2019

The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC.

Lung Cancer 2019 01 29;127:153-163. Epub 2018 Nov 29.

Department of Medicine and Surgery, University of Parma, Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183067
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.11.038DOI Listing
January 2019

Upfront osimertinib in -mutated non-small cell lung cancer: is brain still a sanctuary?

Ann Transl Med 2018 Dec;6(Suppl 2):S110

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.11.69DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330596PMC
December 2018

Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?

Nat Rev Clin Oncol 2018 11;15(11):694-708

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0081-4DOI Listing
November 2018

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall.

Cancer Treat Rev 2018 May 24;66:82-94. Epub 2018 Apr 24.

Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.04.006DOI Listing
May 2018

No room for statins in the quest for survival benefits in small cell lung cancer.

Transl Lung Cancer Res 2018 Apr;7(Suppl 2):S131-S133

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.03.07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943234PMC
April 2018

Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start.

Transl Lung Cancer Res 2018 Apr;7(Suppl 2):S103-S106

INSERM, U981, Gustave Roussy Cancer Campus, Université Paris Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.02.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943229PMC
April 2018

Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature.

Clin Lung Cancer 2018 03 28;19(2):e151-e161. Epub 2017 Oct 28.

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.10.008DOI Listing
March 2018

Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.

Lung Cancer 2017 10 29;112:10-15. Epub 2017 Jul 29.

Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.004DOI Listing
October 2017

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.

Lung Cancer 2017 10 7;112:62-68. Epub 2017 Aug 7.

Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.002DOI Listing
October 2017

Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report.

Curr Drug Targets 2016 ;17(15):1755-1760

University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450117666160112114756DOI Listing
August 2017

Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms.

Tumori 2017 Jul 1;103(4):325-337. Epub 2017 Jul 1.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000663DOI Listing
July 2017

Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition.

Cancer Treat Rev 2017 Apr 12;55:83-95. Epub 2017 Mar 12.

Medical Oncology Unit, Univeristy Hospital of Parma, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.02.010DOI Listing
April 2017

Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC.

J Thorac Oncol 2016 11 8;11(11):1819-1836. Epub 2016 Jun 8.

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.05.027DOI Listing
November 2016

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors.

Transl Lung Cancer Res 2016 Jun;5(3):301-21

1 INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Sud, Villejuif, France ; 2 Medical Oncology Unit, University Hospital of Parma, Parma, Italy ; 3 Department of Oncology, AOU San Luigi (Orbassano), University of Turin, Italy ; 4 Medical Oncology, AO Ordine Mauriziano, Turin, Italy ; 5 Division of Pathology, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy ; 6 Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy ; 7 Operative Unit of Pathology, Azienda USL Valle d'Aosta, Aosta, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.06.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931127PMC
June 2016

CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients.

Tumour Biol 2015 Aug 3;36(8):5943-51. Epub 2015 Mar 3.

Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-015-3269-6DOI Listing
August 2015

NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI.

Lung Cancer 2013 Oct 13;82(1):177-8. Epub 2013 Aug 13.

Medical Oncology Unit, University Hospital, Parma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.07.018DOI Listing
October 2013